RUTH EARLEY: Open Payments
NPI 1427023597 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$59 in 4 payments from 4 companies in 2025. Trend: 2023 $279 · 2024 $233 · 2025 $59
Food & beverage: $59
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Ardelyx, Inc. | 1 | $14 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: ENTYVIO, REZDIFFRA, IBSRELA, XIFAXAN.
Industry payments across UT — which companies pay providers there.
